<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04740983</url>
  </required_header>
  <id_info>
    <org_study_id>500/62</org_study_id>
    <nct_id>NCT04740983</nct_id>
  </id_info>
  <brief_title>Ultraviolet Radiation Forecasting Based Heliotherapy For Psoriasis in Bangkok, Thailand</brief_title>
  <official_title>The Study of Efficacy and Safety of UV Forecasting Based Heliotherapy For Psoriasis in Bangkok, Thailand: A Split-side Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King Chulalongkorn Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Due to limited number of phototherapy centres and shortage of qualified phototherapy&#xD;
      practitioners, heliotherapy has become a promising treatment alternative in Thailand where&#xD;
      patients effortlessly receive supervised sun-bathing treatments from their homes whenever&#xD;
      they are convenient. We used newly designed deep neural network UV forecasting model&#xD;
      developed by using our 10 year-retrospective Solar UV irradiance (280-400 nm) retrieved from&#xD;
      a ground based platform at Atmosperic laboratory, Silpakorn University, Nakhon Pathom,&#xD;
      Thailand (13.82N 100.04E, 30 m above mean sea level). This model achieved a next-day forecast&#xD;
      error of less than 12% which has been the most accurate prediction to date. We designed our&#xD;
      10week heliotherapy regimen based on the predicted anti psoriasis effective irradiance&#xD;
      values. We studied efficacy and safety of the 12-week heliotherapy regimen for psoriasis on&#xD;
      only ruled acceptable clear sky days in Bangkok, Thailand&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We studied efficacy and safety of the 16-week heliotherapy regimen for psoriasis on only&#xD;
      ruled acceptable clear sky days in Bangkok, Thailand&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 15, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of Targeted PASI score</measure>
    <time_frame>16 weeks</time_frame>
    <description>PASI score for targeted plagues will be evaluated by two independent dermatologists (EB, PA) from standard digital photographs.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of possible acute side effects after sun bathing</measure>
    <time_frame>16 weeks</time_frame>
    <description>Potential acute effects of the exposure of full-spectrum solar radiation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Psoriasis Vulgaris</condition>
  <arm_group>
    <arm_group_label>Heliotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>will receive 16-week heliotherapy regimen based on the predicted anti psoriasis effective irradiance values along with olive oil (in-house formulation)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>only will receive olive oil (in-house formulation)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Heliotherapy (a sole sun-bathing)</intervention_name>
    <description>16-week heliotherapy regimen based on the predicted anti psoriasis effective irradiance values.</description>
    <arm_group_label>Heliotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A psoriasis patient who indicate to have phototherapy and have lesional plagues&#xD;
             systemically either on the front-back or left-right.&#xD;
&#xD;
          -  A participant is based in Bangkok&#xD;
&#xD;
          -  A participant is capable to understand and learn how to use our in-house assembled UV&#xD;
             metre and web-based heliotherapy platform.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A participant has any sun-sensitive conditions including photo-aggravated&#xD;
             photodermatoses and on photosentisitive drug treatments.&#xD;
&#xD;
          -  Breast-feeding, pregnant individuals.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>May 23, 2020</study_first_submitted>
  <study_first_submitted_qc>February 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2021</study_first_posted>
  <last_update_submitted>February 2, 2021</last_update_submitted>
  <last_update_submitted_qc>February 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Einapak Boontaveeyuwat, MD</investigator_full_name>
    <investigator_title>Consultant dermatologist, Dr.</investigator_title>
  </responsible_party>
  <keyword>Heliotherapy</keyword>
  <keyword>sun-bathing</keyword>
  <keyword>psoriasis</keyword>
  <keyword>ultraviolet radiation</keyword>
  <keyword>forecasting</keyword>
  <keyword>Thailand</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psoriasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

